GlassScriptPhysician profile
Christopher Brian Rogers
NPI 1285626226
$1,882.01
in general payments reported to CMS, 2019-2025
16 companies · $469 in 2025
The $469 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $818 · 2020: $197 · 2021: $151 · 2022: $88.82 · 2023: $105 · 2024: $53.84 · 2025: $469.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $627.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $627.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $456.20 | 2025 | Atriclip Laa Exclusion System, Atricure Cryoice Cryoablation System (Cryo2), Synergy Ablation System |
| Boston Scientific Corporation | $307.14 | 2019-2024 | Angiojet Ultra 5000a |
| Pfizer INC. | $276.16 | 2019-2022 | |
| Amarin Pharma, INC. | $176.26 | 2019-2022 | |
| Amgen INC. | $117.34 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $115.06 | 2019-2025 | Lifevest |
| Edwards Lifesciences Corporation | $100.20 | 2019 | |
| Medtronic, INC. | $87.55 | 2023 | Pulseselect |
| Regeneron Healthcare Solutions, INC. | $73.75 | 2019 | |
| Novartis Pharmaceuticals Corporation | $68.69 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.62 | 2019 | |
| Abbott Laboratories | $24.03 | 2020 | |
| Portola Pharmaceuticals, LLC | $14.93 | 2020 | |
| Janssen Pharmaceuticals, INC | $14.81 | 2019 | |
| Medtronic Vascular, INC. | $12.83 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $12.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Rogers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.